Vincent O'Neill - Mar 14, 2022 Form 4 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Role: Chief Medical Officer
Signature: /s/ Javier Rodriguez, as Attorney-in-Fact for Vincent O'Neill, M.D.
Stock symbol: BTAI
Transactions as of: Mar 14, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/16/2022, 04:20 PM
Next filing: Jan 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BTAI	Restricted Stock Units	Award	$0	+8.34K		$0.00	8.34K	Mar 14, 2022	Common Stock	8.34K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2	The RSUs will vest and settle as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of Restricted Stock Units at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.